Skip to content

t360 dialogue podcast series

Please complete this activity then scroll to the end and click 'Done'
Thank you for completing this CPD activity. Please complete this evaluation, we will then provide you with a certificate so that you can claim CPD credits.
1.First Name
2.Last Name(Required.)
3.Contact Email
4.Contact telephone
5.Please indicate to the nearest hour the number of podcast content completed
6.Please rate to what degree your learning needs were met:
7.Please rate how well the following learning outcome was met: Identify the latest issues that impact on treatment with anticoagulation agents for stroke prevention and management of thromboembolic disorders.
8.Please rate how well the following learning outcome was met: Manage anticoagulation treatment in patients with comorbidities.
9.Please rate how well the following learning outcome was met: Manage anticoagulation treatment in patients with issues that can complicate the treatment decision.
10.Please rate how well the following learning outcome was met: Interpret the latest RCT and post-marketing data that underpins and guides treatment with anticoagulation agents.
11.Please rate to what degree this activity is relevant to your practice
12.Has this activity contributed to a systems-based patient safety outcome for your practice?
13.How useful has this meeting been in providing solutions to the current treatment challenges faced by GPs?
14.As a result of the education you have received, do you have increased confidence in managing AF/VTE and related CV disease?
15.Would you recommend this education to a colleague?
Please click 'Done' below to submit your questionnaire
The TGA encourages health professionals to report adverse events to medicines and vaccines. Suspected adverse events reported by health professionals provide important information for the TGA’s safety monitoring program. For further details on reporting a suspected adverse event, please refer to the TGA website: www.tga.gov.au. If you report an adverse event associated with the use of ELIQUIS to the TGA, please provide Pfizer or BMS with a copy.